Designed with the practicing clinician in mind, Idiopathic Pulmonary Fibrosis provides a succinct, easy-to-digest overview of this challenging condition in which the cause of thickening lung tissue is unknown. This concise resource by Drs. Kevin K. Brown and Jeff Swigris provides essential information for the physician who sees pulmonary fibrosis patients, including epidemiology, genetics and biomarkers, pathology, diagnosis, disease monitoring, and therapeutics intended to improve the patient's lifespan and quality of life. Covers the process of making the diagnosis of idiopathic pulmonary fibrosis, as well as IPF look-alikes: uncharacterized PF, CTD-ILD, and cHP. Details today's available therapeutics, including Rx, rehabilitation, O2, Tx, and treating comorbidities: OSA, GERD, and PH. Consolidates today's available information on this timely topic into one convenient resource.

The aim of this book is to present articles that are stimulating to read and inform readers with the most up-to-date clinical research. The articles incorporate the latest developments on a variety of topics in pulmonary medicine, therapy, and related mutlisystem disorders with varied manifestations. Emphasis is given to air quality and lung health, therapeutic management of airway reactivity and cough sensitivity linked to mucous clearance ability, ventilatory and cellular effects of hypoxia, influenza epidemics and persistently dismal vaccination coverage rate, disorders of mixed provenance and genetic background affecting lung parenchyma such as cystic fibrosis or Langerhans cell histiocytosis, and others. New diagnostic strategies and therapeutic management will hopefully serve to enhance the way patient care is delivered and thus clinical outcomes. Being a blend of medical research and practice the book addresses the needs of respiratory scientists and physicians, and allied health professionals.

Change is an inherent feature of all aspects of clinical practice and patient management. This book seeks to contribute to presenting novel knowledge in various fields of clinical work. The articles tackle transdisciplinary topics and focus on the underlying mechanisms of clinical disorders, their prevention and management. The themes addressed include allergy and pseudoallergy in the pediatric population, influenza-related infections and their sequelae, which continues to be a scourge in the developing world, the risk of lung cancer repeats and their management, viral hepatitis that may lead to hepatocarcinoma, respiratory consequences of diaphragmatic hernias, disorders of steroid hormone metabolism, and others. The articles bring the updated strategies, research, and best practices to improve outcomes and to deliver state-of-the-art clinical care to patients. The book will be of interest to physicians, academic scientists, and researchers who are keen in sharing the latest medical practice developments.

This issue of Chest Medicine Clinics focuses on Interventional Pulmonology, with topics including: Flexible bronchoscopy; Radiology for mediastinal lymph node station in lung cancer diagnosis and staging; Lung cancer screening; Early lung cancer detection; Palliative care and interventional pulmonology; Anesthesia for flexible and rigid bronchoscopy; Mediastinal and pulmonary pathology: Specimen collection and processing; Bronchial Thermoplasty: A nonpharmacological therapy for severe asthma; Bronchoscopic lung volume reduction; Malignant pleural effusion: From diagnostics to therapeutics; Intrapleural therapeutics; Percutaneous dilational tracheostomy; Tracheobronchial stenosis and Tracheobroncho malacia: diagnostic and therapeutic dilemmas; Pediatric interventional pulmonology; The Business of Bronchoscopy: How to set up an Interventional Pulmonology Program; Bronchoscopic therapies for peripheral lung malignancies; and Bronchial Thermoplasty: A nonpharmacological therapy for severe asthma.

This issue of Clinics in Chest Medicine focuses on Pulmonary Considerations in Solid Organ and Hematopoietic Stem Cell Transplantation. Editors Vivek Ahya and Joshua Diamond have assembled an expert team of authors on topics such as: Overview of HSCT Transplantation and future directions in treatment of hematologic malignancies; Early Pulmonary complications of HSCT and Prognosis of Respiratory FailureLate Pulmonary complications of HSCT; Overview of Lung Transplantation, Heart-lung transplantation, Lung-Liver transplantation and combined HSCT and lung transplantation; Primary graft dysfunction after Lung Transplantation; Extracorporeal life support (ECLS) in lung transplantation; Evaluation and Management of the potential lung donor (including EVLP); Acute rejection & antibody mediated rejection in lung transplantation; Chronic lung allograft dysfunction (CLAD); Airway complications in lung transplantation; PTLD in solid organ and HSCT transplantation; Respiratory Bacterial and Mycobacterial Infections in solid organ transplantation and HSCT; Respiratory Viral infections in solid organ transplantation and HSCT; Respiratory Fungal infections in solid organ and hematopoietic stem cell transplantation; Non-infectious pulmonary complications of Liver, Heart and Kidney Transplantation; Hepatopulmonary syndrome and portal- pulmonary hypertension in liver failure; implications for liver transplantation.

This book is a practical guide to the diagnosis and management of tuberculosis. Presented in a step by step approach, the text provides the latest information in the specialty, guiding clinicians through the history of the disease, its epidemiology, pathogenesis and pathology, to clinical presentation, imaging, diagnosis, and treatment options. The book is enhanced by illustrations and figures, and provides a clear understanding of the management of the disease from a global perspective and the challenges associated with tuberculosis care. Key points Practical guide to diagnosis and management of tuberculosis Presented in a step by step approach, providing latest information in the field Includes illustrations and figures to assist learning Provides clear understanding of challenges associated with tuberculosis care

Airborne allergies afflict millions of Americans, and are now the sixth leading cause of chronic illness. But now allergy victims can fight back with the most up-to-date information available anywhere. Learn the latest techniques for controlling symptoms through conventional medicines and diet, how to make your home allergen-free, and discover the exciting promise offered by lgE blockers and improved immunotherapy. Detailed discussions of allergy myths and how to find a physician who can offer real relief are also included in this essential guide.

Respiratory Syncytial Virus (RSV) is a ubiquitous and highly contagious virus belonging to the Paramyxoviridae family. RSV is the most common cause of bronchiolitis and hospitalisation during the first year of life and it might be associated with an increased risk of recurrent wheeze, asthma as well as with decreased respiratory function in school-aged children. In Chapter One, the authors report the most updated evidences for the environmental prophylaxis and summarise current recommendations about targeted palivizumab immunisation and ongoing trials on RSV vaccine development. Chapter Two summarises the most recent literature regarding acute bronchiolitis to provide an evidence-based approach to the management and treatment of this disease. In Chapter Three, the authors review risk factors associated with hospitalisation and pediatric intensive care unit admission. The final chapter illustrates a practical, pathophysiological and step up approach to children affected by severe bronchiolitis.

This issue of Clinics in Chest Medicine focuses on Pulmonary Complications of Non-Pulmonary Malignancy. Editors Guang-Shing Cheng and Jennifer Possick have assembled an expert team of authors on topics such as: Pulmonary manifestations of non-pulmonary solid malgnancies; Pulmonary manifestations of leukemia and lymphoma; Radiation pneumonitis; Toxicities from conventional chemotherapy; Toxicities from novel targeted therapies; Bacterial pneumonia; Fungal pneumonia; Viral pneumonia; IPS and other early onset non-infectious pulmonary syndromes; Pulmonary GVHD and other late-onset non-infectious pulmonary syndromes; Pulmonary function and pre-transplant risk assessment; Diagnostic Evaluation of Pulmonary Abnormalities in Hematologic Malignancy and HCT; Acute respiratory failure in patients with non-pulmonary malignancy; Critical care prognosis and outcomes in patients with non-pulmonary malignancy; and Palliative and end-of-life care.